Back to search

Article

Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy

2021-04-28

Abstract excerpt

The deubiquitylase USP30 is an actionable target considered for treatment of conditions associated with defects in the PINK1/Parkin pathway leading to mitophagy. These include Parkinson’s disease and pulmonary fibrosis. We provide a detailed cell biological characterisation of a benzenesulphonamide molecule, compound 39, that has previously been reported to inhibit USP30 in an in vitro enzymatic assay. The curren...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6fd478f-942e-5acc-92e2-c30c971dbf1d
DOI
10.1101/2021.04.28.441730
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagyDOI 10.1101/2021.04.28.441730
Select a neighboring publication to make it the new centre.